Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...

President Trump and British Prime Minister Keir Starmer announced a new trade agreement. Other countries, including China, ...

The imposition of tariffs on pharmaceutical imports - either directly or indirectly through raw materials and active ...

BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, May 5, 2025, at 8:00 a.m. EDT (2:00 p.m. CEST) to report its financial results ...

Baxter International, a prominent health care and pharmaceutical manufacturer, reports that President Trump's tariffs will ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Pfizer CEO Albert Bourla said the pharmaceutical ... the company behind fast food chains like Taco Bell and Pizza Hut, expects little impact from tariffs on its supply chain, CFO Chris Turner ...

Pfizer's CEO said tariff uncertainty is hindering the company from making big investments in the US. Albery Bourla said there could be "tremendous investments" in R&D and manufacturing in the US.

The U.S. imports both pharmaceutical ingredients and finished products, but it remains unclear how much of an impact the proposed tariffs would have on these imports or how much would be passed on ...

Unlike many companies facing trade-policy shifts, Pfizer left its full-year forecast intact on Tuesday. In its earnings release, the company pointed out that its guidance “does not currently include ...